| Dr Timothy Andrew Mcgraw, MD | |
|
833 Saint Vincents Dr, Birmingham, AL 35205-1606 | |
| (205) 933-4640 | |
| (205) 939-4519 |
| Full Name | Dr Timothy Andrew Mcgraw |
|---|---|
| Gender | Male |
| Speciality | Dermatology |
| Experience | 30 Years |
| Location | 833 Saint Vincents Dr, Birmingham, Alabama |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1265433494 | NPI | - | NPPES |
| 512-00033 | Other | AL | BCBS PROVIDER NUMBER |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207N00000X | Dermatology | 9412091-1205 (Utah) | Secondary |
| 207N00000X | Dermatology | MD.35820 (Alabama) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Southview Medical Group, Pc | 8729979794 | 40 |
News Archive
A recent study describes the estimated risk of COVID-19 transmission via aerosols in many different situations, as well as the expected reduction in risk associated with the use of various preventive measures.
Abbott today announced positive 30-day results from the first 101 patients enrolled in the second phase of the ABSORB trial. Patients treated with Abbott's bioresorbable vascular scaffold (BVS), under clinical investigation in Europe, demonstrated no cases of blood clots (thrombosis), no need for repeat procedures (ischemia-driven target lesion revascularization) and a very low rate of major adverse cardiac events (MACE(1) rate of 2.0 percent) at 30 days.
Taking daily recommended dosages of ibuprofen and acetaminophen caused a substantially greater increase over placebo in the amount of quadriceps muscle mass and muscle strength gained during three months of regular weight lifting, in a study by physiologists at the Human Performance Laboratory, Ball State University.
Agfa HealthCare recently signed on as a pilot vendor for the Radiology Society of North America's Image Share Validation Program, a conformity assessment program that is designed to establish standards across image-sharing vendors and at healthcare organizations.
› Verified 3 days ago
| Entity Name | Southview Medical Group, Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1801860333 PECOS PAC ID: 8729979794 Enrollment ID: O20040322000490 |
News Archive
A recent study describes the estimated risk of COVID-19 transmission via aerosols in many different situations, as well as the expected reduction in risk associated with the use of various preventive measures.
Abbott today announced positive 30-day results from the first 101 patients enrolled in the second phase of the ABSORB trial. Patients treated with Abbott's bioresorbable vascular scaffold (BVS), under clinical investigation in Europe, demonstrated no cases of blood clots (thrombosis), no need for repeat procedures (ischemia-driven target lesion revascularization) and a very low rate of major adverse cardiac events (MACE(1) rate of 2.0 percent) at 30 days.
Taking daily recommended dosages of ibuprofen and acetaminophen caused a substantially greater increase over placebo in the amount of quadriceps muscle mass and muscle strength gained during three months of regular weight lifting, in a study by physiologists at the Human Performance Laboratory, Ball State University.
Agfa HealthCare recently signed on as a pilot vendor for the Radiology Society of North America's Image Share Validation Program, a conformity assessment program that is designed to establish standards across image-sharing vendors and at healthcare organizations.
› Verified 3 days ago
| Entity Name | Naaman Clinic, Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1194183749 PECOS PAC ID: 5799082699 Enrollment ID: O20160321000645 |
News Archive
A recent study describes the estimated risk of COVID-19 transmission via aerosols in many different situations, as well as the expected reduction in risk associated with the use of various preventive measures.
Abbott today announced positive 30-day results from the first 101 patients enrolled in the second phase of the ABSORB trial. Patients treated with Abbott's bioresorbable vascular scaffold (BVS), under clinical investigation in Europe, demonstrated no cases of blood clots (thrombosis), no need for repeat procedures (ischemia-driven target lesion revascularization) and a very low rate of major adverse cardiac events (MACE(1) rate of 2.0 percent) at 30 days.
Taking daily recommended dosages of ibuprofen and acetaminophen caused a substantially greater increase over placebo in the amount of quadriceps muscle mass and muscle strength gained during three months of regular weight lifting, in a study by physiologists at the Human Performance Laboratory, Ball State University.
Agfa HealthCare recently signed on as a pilot vendor for the Radiology Society of North America's Image Share Validation Program, a conformity assessment program that is designed to establish standards across image-sharing vendors and at healthcare organizations.
› Verified 3 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Timothy Andrew Mcgraw, MD 833 Saint Vincents Dr, Birmingham, AL 35205-1606 Ph: (205) 933-4640 | Dr Timothy Andrew Mcgraw, MD 833 Saint Vincents Dr, Birmingham, AL 35205-1606 Ph: (205) 933-4640 |
News Archive
A recent study describes the estimated risk of COVID-19 transmission via aerosols in many different situations, as well as the expected reduction in risk associated with the use of various preventive measures.
Abbott today announced positive 30-day results from the first 101 patients enrolled in the second phase of the ABSORB trial. Patients treated with Abbott's bioresorbable vascular scaffold (BVS), under clinical investigation in Europe, demonstrated no cases of blood clots (thrombosis), no need for repeat procedures (ischemia-driven target lesion revascularization) and a very low rate of major adverse cardiac events (MACE(1) rate of 2.0 percent) at 30 days.
Taking daily recommended dosages of ibuprofen and acetaminophen caused a substantially greater increase over placebo in the amount of quadriceps muscle mass and muscle strength gained during three months of regular weight lifting, in a study by physiologists at the Human Performance Laboratory, Ball State University.
Agfa HealthCare recently signed on as a pilot vendor for the Radiology Society of North America's Image Share Validation Program, a conformity assessment program that is designed to establish standards across image-sharing vendors and at healthcare organizations.
› Verified 3 days ago
Callie Roberts Hill, Dermatology Medicare: Medicare Enrolled Practice Location: 1927 1st Ave N, Birmingham, AL 35203 Phone: 205-933-0987 Fax: 205-930-1750 | |
Carly Elston, M.D. Dermatology Medicare: Accepting Medicare Assignments Practice Location: 500 22nd St S, Birmingham, AL 35233 Phone: 205-934-9999 | |
Tiffany Mayo, Dermatology Medicare: Accepting Medicare Assignments Practice Location: 1717 6th Ave S, Birmingham, AL 35233 Phone: 800-822-8816 | |
Daniel Bergman, MD Dermatology Medicare: Accepting Medicare Assignments Practice Location: 619 19th St S, Birmingham, AL 35249 Phone: 205-934-4011 Fax: 205-297-9411 | |
Carlton Phillips, Dermatology Medicare: Accepting Medicare Assignments Practice Location: 2100 16th Ave S, Birmingham, AL 35205 Phone: 205-933-0987 Fax: 205-930-1758 | |
Katherine Flanagan, MD Dermatology Medicare: Accepting Medicare Assignments Practice Location: 813 Shades Creek Pkwy, Suite 205, Birmingham, AL 35209 Phone: 205-578-1799 Fax: 205-578-3158 | |
Vijay Balakrishnan, MD Dermatology Medicare: Medicare Enrolled Practice Location: 510 20th St S Ste 858, Birmingham, AL 35233 Phone: 205-934-5188 |